Annaka Nava is a lawyer at Goodwin Procter LLP specializing in patent litigation. She advises life sciences companies in all stages of complex patent litigations in federal district courts and the International Trade Commission, from pre-suit investigations and patent portfolio analyses through trial. Annaka has extensive experience in matters covering pharmaceuticals, biotechnology, and medical devices. Prior to practicing law, Annaka conducted primary scientific research on the genetic causes of breast cancer at The Sidney Kimmel Comprehensive Cancer Center in Baltimore. She holds a master’s degree in pathobiology from the Johns Hopkins University School of Medicine.
Lana Shiferman is a lawyer at Goodwin Procter LLP focusing on patent litigation. She has represented clients in all phases of litigation from pre-litigation counseling through trial and appeal. Lana has represented both patent owners and patent defendants in federal courts throughout the country and at the International Trade Commission. Lana has also represented clients in trans-border disputes in countries such as the UK, Germany, South Korea, Japan and Taiwan. She has litigated cases involving a broad range of technologies including diagnostics, artificial organ tissue, blood glucose monitoring systems and pharmaceutical products.
The women’s health market offers enormous potential for investment and innovation. While challenges related to systemic inequalities remain, progress in venture capital funding is encouraging. Likewise, the overall increase in patent filings related to breast cancer, endometriosis, and other conditions appears to reflect a growing interest in women’s health.